2m 2m 2m 2m 2m 2m 2m
Novo Nord -B- (NONOF)
OTC
$43.19-$0.95 (-2.16%)
Price as of Sep 11, 2026- N/AMarket Cap
- -15.35%1-Year Change
- Drug Manufacturers - GeneralIndustry
Novo Nord -B- (NONOF)
$43.19-$0.95 (-2.16%)
Key Performance
More- Earnings Score: N/A
- Momentum Score: N/A
- True Yield: N/A
- Financial Health Score: N/A
Latest Research & News
No data found
Peers
Statistics
MoreDay Range
$42.00
$43.93
$43.19
1-Year Range
$35.03
$63.20
$43.19
Latest Close$43.19
Change
-$0.95 (-2.21%)
Volume14,651
Information as of 09/11/2026
Company Profile
NOVO NORDISK A/S B NEW
N/A
Market Cap
N/A
Net Income
Sector: Healthcare
Industry: Drug Manufacturers - General
NOVO NORDISK A/S B NEW
Key Executives
- Karsten Munk Knudsen
- Martin Holst Lange
- Emil Kongshøj Larsen
- Hong Chow
- Tania Sabroe
Current Ownership Distribution
- Other4.4B (99.38%)
- Mutual Funds27.4M (0.62%)
- Institutions320,608 (0.007%)
- Insiders0 (0.00%)